7 Einträge gefunden

1. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group

   1. Eckert, Cornelia
   2. Henze, Günter
   3. Seeger, Karlheinz
   4. Hagedorn, Nikola
   5. Mann, Georg
   6. Panzer-Grümayer, Renate
   7. Peters, Christina

   2013 - Forschungsinformationssystem des UKE
2. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

   1. Eckert, Cornelia
   2. von Stackelberg, Arend
   3. Seeger, Karl
   4. Groeneveld, Tom W L
   5. Peters, Christina
   6. Klingebiel, Thomas
   7. Borkhardt, Arndt

   2013 - Forschungsinformationssystem des UKE
3. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome

   1. Meyr, Franziska
   2. Escherich, Gabriele
   3. Mann, Georg
   4. Klingebiel, Thomas
   5. Kulozik, Andreas
   6. Rossig, Claudia
   7. Schrappe, Martin

   2013 - Forschungsinformationssystem des UKE
4. Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.

   1. von Stackelberg, Arend
   2. Völzke, Enrico
   3. Kühl, Jörn-Sven
   4. Seeger, Karl
   5. Schrauder, André
   6. Escherich, Gabriele
   7. Henze, Günter

   2011 - Forschungsinformationssystem des UKE
5. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.

   1. Borgmann, Anja
   2. Zinn, Christina
   3. Hartmann, Reinhard
   4. Herold, Ralf
   5. Kaatsch, Peter
   6. Escherich, Gabriele
   7. Möricke, Anja

   2008 - Forschungsinformationssystem des UKE
6. Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group.

   1. Hagedorn, Nikola
   2. Acquaviva, Cécile
   3. Fronkova, Eva
   4. von Stackelberg, Arend
   5. Barth, Andrea
   6. Zur Stadt, Udo
   7. Schrauder, André

   2007 - Forschungsinformationssystem des UKE
7. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.

   1. Berthold, Frank
   2. Boos, Joachim
   3. Burdach, Stefan
   4. Erttmann, Rudolf
   5. Henze, Günter
   6. Hermann, Johann
   7. Klingebiel, Thomas

   2005 - Forschungsinformationssystem des UKE